Bluejay Diagnostics Inc
NASDAQ:BJDX
Bluejay Diagnostics Inc
NASDAQ:BJDX
Price:
1.98
USD
2.06%
Market Closed
Market Cap:
$1.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bluejay Diagnostics Inc
NASDAQ:BJDX
|
US |
|
G
|
Geo-Jade Petroleum Corp
SSE:600759
|
CN |
|
Nihon Nohyaku Co Ltd
TSE:4997
|
JP |
|
Materion Corp
NYSE:MTRN
|
US |
|
MedAvail Holdings Inc
OTC:MDVLQ
|
US |
|
Ador Multi Products Ltd
BSE:523120
|
IN |
|
Stamford Land Corporation Ltd
SGX:H07
|
SG |
|
Sharp Corp
TSE:6753
|
JP |
|
Hotel Sahid Jaya International Tbk PT
IDX:SHID
|
ID |
|
Rainbow Rare Earths Ltd
LSE:RBW
|
GG |
Balance Sheet
Balance Sheet Decomposition
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
Balance Sheet Decomposition is not available for
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
Balance Sheet
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
1
|
19
|
10
|
2
|
4
|
5
|
|
| Cash Equivalents |
0
|
1
|
19
|
10
|
2
|
4
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
1
|
1
|
0
|
|
| Total Current Assets |
0
|
1
|
21
|
12
|
3
|
5
|
5
|
|
| PP&E Net |
1
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| PP&E Gross |
1
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
2
+65%
|
21
+1 283%
|
14
-36%
|
5
-64%
|
7
+37%
|
7
+7%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
1
|
2
|
2
|
1
|
1
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+34%
|
1
-65%
|
2
+209%
|
2
0%
|
1
-53%
|
1
+23%
|
|
| Equity | ||||||||
| Common Stock |
2
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
4
|
8
|
17
|
27
|
35
|
42
|
|
| Additional Paid In Capital |
0
|
0
|
28
|
29
|
30
|
40
|
47
|
|
| Total Equity |
0
N/A
|
0
+28%
|
20
N/A
|
12
-43%
|
3
-75%
|
6
+98%
|
6
+4%
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+65%
|
21
+1 283%
|
14
-36%
|
5
-64%
|
7
+37%
|
7
+7%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
